Cargando…

Knockdown of NIR Suppresses Breast Cancer Cell Proliferation via Promoting FOXO3

BACKGROUND: Novel inhibitor of histone acetyltransferase repressor (NIR), a corepressor with a novel inhibitor of histone acetyltransferase (INHAT) activity, has been reported to be a negative modulator of p53 and a regulator of the cell cycle in cancer cells. However, the role of NIR in the progres...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Bolin, Dong, Chengcheng, Wang, Fang, Wu, Jiacai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837597/
https://www.ncbi.nlm.nih.gov/pubmed/33519211
http://dx.doi.org/10.2147/OTT.S287464
_version_ 1783642988521455616
author Chen, Bolin
Dong, Chengcheng
Wang, Fang
Wu, Jiacai
author_facet Chen, Bolin
Dong, Chengcheng
Wang, Fang
Wu, Jiacai
author_sort Chen, Bolin
collection PubMed
description BACKGROUND: Novel inhibitor of histone acetyltransferase repressor (NIR), a corepressor with a novel inhibitor of histone acetyltransferase (INHAT) activity, has been reported to be a negative modulator of p53 and a regulator of the cell cycle in cancer cells. However, the role of NIR in the progression of breast cancer remains elusive. MATERIALS AND METHODS: Oncomine database was used to analyze the mRNA levels and prognosis value of NIR in breast cancer. We performed loss-of-function and gain-of-function studies using lentivirus expressing shRNA targeting NIR, enhancer of zeste homolog 2 (EZH2) and forkhead box O3 (FOXO3) or lentivirus expressing NIR or FOXO3, respectively. Cell proliferation and colony formation assays were performed. Co-immunoprecipitation (Co-IP) and immunoprecipitation (IP) were performed to identify the interaction between NIR and polycomb repressive complex 2 (PRC2) subunits. ChIP assay was used to identify the enrichment of NIR, EZH2, H3K27ac and H3K27me3 at the FOXO3 promoter region and the regulation of H3K27 modification at the FOXO3 promoter by NIR. RESULTS: High levels of NIR expression were correlated with poor prognosis in breast cancer patients. Knockdown of NIR suppressed the proliferation of breast cancer cells. Mechanically, NIR was recruited by EZH2 to the promoter vicinity of FOXO3 via direct protein–protein interaction. Silencing NIR increased H3K27ac and decreased H3K27me3 levels at the FOXO3 promoter, resulting in enhancing FOXO3 expression. In accordance with this, growth inhibition of breast cancer cells caused by silencing of NIR could be reversed by FOXO3 knockdown. CONCLUSION: NIR knockdown inhibited proliferation by switching the H3K27me3 and H3K27ac marks at the FOXO3 promoter to promote FOXO3 transcription, and this effect depends on the physical interaction between NIR and PRC2 in breast cancer cells. Our results suggest that NIR might be a potential target for breast cancer treatment.
format Online
Article
Text
id pubmed-7837597
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-78375972021-01-28 Knockdown of NIR Suppresses Breast Cancer Cell Proliferation via Promoting FOXO3 Chen, Bolin Dong, Chengcheng Wang, Fang Wu, Jiacai Onco Targets Ther Original Research BACKGROUND: Novel inhibitor of histone acetyltransferase repressor (NIR), a corepressor with a novel inhibitor of histone acetyltransferase (INHAT) activity, has been reported to be a negative modulator of p53 and a regulator of the cell cycle in cancer cells. However, the role of NIR in the progression of breast cancer remains elusive. MATERIALS AND METHODS: Oncomine database was used to analyze the mRNA levels and prognosis value of NIR in breast cancer. We performed loss-of-function and gain-of-function studies using lentivirus expressing shRNA targeting NIR, enhancer of zeste homolog 2 (EZH2) and forkhead box O3 (FOXO3) or lentivirus expressing NIR or FOXO3, respectively. Cell proliferation and colony formation assays were performed. Co-immunoprecipitation (Co-IP) and immunoprecipitation (IP) were performed to identify the interaction between NIR and polycomb repressive complex 2 (PRC2) subunits. ChIP assay was used to identify the enrichment of NIR, EZH2, H3K27ac and H3K27me3 at the FOXO3 promoter region and the regulation of H3K27 modification at the FOXO3 promoter by NIR. RESULTS: High levels of NIR expression were correlated with poor prognosis in breast cancer patients. Knockdown of NIR suppressed the proliferation of breast cancer cells. Mechanically, NIR was recruited by EZH2 to the promoter vicinity of FOXO3 via direct protein–protein interaction. Silencing NIR increased H3K27ac and decreased H3K27me3 levels at the FOXO3 promoter, resulting in enhancing FOXO3 expression. In accordance with this, growth inhibition of breast cancer cells caused by silencing of NIR could be reversed by FOXO3 knockdown. CONCLUSION: NIR knockdown inhibited proliferation by switching the H3K27me3 and H3K27ac marks at the FOXO3 promoter to promote FOXO3 transcription, and this effect depends on the physical interaction between NIR and PRC2 in breast cancer cells. Our results suggest that NIR might be a potential target for breast cancer treatment. Dove 2021-01-22 /pmc/articles/PMC7837597/ /pubmed/33519211 http://dx.doi.org/10.2147/OTT.S287464 Text en © 2021 Chen et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Chen, Bolin
Dong, Chengcheng
Wang, Fang
Wu, Jiacai
Knockdown of NIR Suppresses Breast Cancer Cell Proliferation via Promoting FOXO3
title Knockdown of NIR Suppresses Breast Cancer Cell Proliferation via Promoting FOXO3
title_full Knockdown of NIR Suppresses Breast Cancer Cell Proliferation via Promoting FOXO3
title_fullStr Knockdown of NIR Suppresses Breast Cancer Cell Proliferation via Promoting FOXO3
title_full_unstemmed Knockdown of NIR Suppresses Breast Cancer Cell Proliferation via Promoting FOXO3
title_short Knockdown of NIR Suppresses Breast Cancer Cell Proliferation via Promoting FOXO3
title_sort knockdown of nir suppresses breast cancer cell proliferation via promoting foxo3
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837597/
https://www.ncbi.nlm.nih.gov/pubmed/33519211
http://dx.doi.org/10.2147/OTT.S287464
work_keys_str_mv AT chenbolin knockdownofnirsuppressesbreastcancercellproliferationviapromotingfoxo3
AT dongchengcheng knockdownofnirsuppressesbreastcancercellproliferationviapromotingfoxo3
AT wangfang knockdownofnirsuppressesbreastcancercellproliferationviapromotingfoxo3
AT wujiacai knockdownofnirsuppressesbreastcancercellproliferationviapromotingfoxo3